NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Asahi Kasei Pharma Venture Capital

Asahi Kasei Pharma Venture Capital

Overview

An evergreen strategic venture fund of Asahi Kasei Pharma Corporation that invests internationally in biopharmaceutical companies. It focuses on private, early-stage biotech, particularly on the development of innovative therapeutics and platforms in areas like immunology, inflammation, kidney disease, neurodegenerative disease, and rare diseases.

Portfolio Companies

1

Investments

Asahi Kasei Pharma Venture Capital investments
CompanyDateStageLead
AzafarosMay 2025Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersJapan
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.